A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds.

A high-content imaging-based screening pipeline for the systematic identification of anti-progeroid compounds.
复制标题

DOI:
10.1016/j.ymeth.2015.08.024
复制
发表时间:
2016-03-01
期刊:
Methods (San Diego, Calif.)
影响因子:
--
通讯作者:
Misteli T
Misteli T
中科院分区:
其他
文献类型:
--
作者:
Kubben N;Brimacombe KR;Donegan M;Li Z;Misteli T

文献摘要

参考文献

被引文献

相似文献

Hutchinson-Gilford早衰综合征(HGPS)是一种早发性致死性早衰疾病,由组成性早衰蛋白(一种核结构蛋白层蛋白a的突变形式)的产生引起。早衰蛋白的存在导致广泛的形态、表观遗传和DNA损伤相关的核缺陷,最终破坏组织和机体功能。假设驱动的方法侧重于HGPS影响途径,已被用于尝试识别具有抗早衰作用的可药物靶点。在这里,我们报告了一种公正的发现HGPS的方法,通过实施高通量,高含量的基于成像的筛选方法,可以系统地识别小分子,防止多种早衰素诱导的衰老缺陷的形成。筛选2816种FDA批准的药物库,我们发现类维生素a是一类新的化合物,可以逆转HGPS患者皮肤成纤维细胞的衰老缺陷。这些发现为发现抗早衰药物开辟了一条新途径。
Hutchinson–Gilford Progeria Syndrome (HGPS) is an early onset lethal premature aging disorder caused by constitutive production of progerin, a mutant form of the nuclear architectural protein lamin A. The presence of progerin causes extensive morphological, epigenetic and DNA damage related nuclear defects that ultimately disrupt tissue and organismal functions. Hypothesis-driven approaches focused on HGPS affected pathways have been used in attempts to identify druggable targets with anti-progeroid effects. Here, we report an unbiased discovery approach to HGPS by implementation of a high-throughput, high-content imaging based screening method that enables systematic identification of small molecules that prevent the formation of multiple progerin-induced aging defects. Screening a library of 2816 FDA approved drugs, we identified retinoids as a novel class of compounds that reverses aging defects in HGPS patient skin fibroblasts. These findings establish a novel approach to anti-progeroid drug discovery.
DOI: 10.18632/aging.100012
发表时间: 2009-01
期刊: Aging
影响因子: --
作者:
Musich PR;Zou Y
通讯作者: Zou Y
DOI: 10.1016/j.tetlet.2011.12.118
发表时间: 2012-03-14
影响因子: 1.8
作者:
Das, Bhaskar C.;Tang, Xiang-Ying;Evans, Todd
通讯作者: Evans, Todd
DOI: 10.1002/embr.201338126
发表时间: 2014-05-01
期刊: EMBO REPORTS
影响因子: 7.7
作者:
Lopez-Mejia, Isabel C.;de Toledo, Marion;Tazi, Jamal
通讯作者: Tazi, Jamal
DOI: 10.1096/fj.07-8598com
发表时间: 2008-02-01
期刊: FASEB JOURNAL
影响因子: 4.8
作者:
Liu, Yiyong;Wang, Youjie;Zou, Yue
通讯作者: Zou, Yue
DOI: 10.1126/scitranslmed.3002346
发表时间: 2011-06-29
影响因子: 17.1
作者:
Cao, Kan;Graziotto, John J.;Collins, Francis S.
通讯作者: Collins, Francis S.